To the Editor,
Thanks for the opportunity to reply to the comments of Sookaromdee and Wiwanitkit 1 on our manuscript. In this correspondence, the colleagues point out that prevaccination information on vaccine recipients' health and immunological status is crucial and that coinfections may occur upon vaccine inoculation and be misinterpreted as side effects. 2 Therefore, a virology profile should be performed in selected cases. Unfortunately, these data were not collected in our manuscript. 3 A prospective registry evaluating immunological status before and after vaccination, enrolling patients with the inherited cardiological disease, is needed to better focus on this important point. Careful knowledge of potential complications after vaccination may be useful for the proper management of these patients.
Santoro F, Crea P, El‐Battrawy I, Brunetti ND. Reply to fever, Covid‐19 vaccination, and Brugada syndrome: Incidence and management: Correspondence J Cardiovasc Electrophysiol. 2022;33:2122. 10.1111/jce.15638
Disclosures: None.
REFERENCES
- 1. Sookaromdee P, & Wiwanitkit V. Fever, Covid‐19 vaccination and Brugada syndrome: incidence and management: correspondence. J Cardiovasc Electrophysiol . 2022. Advance online publication. 10.1111/jce.15636 [DOI] [PMC free article] [PubMed]
- 2. Kebayoon A, & Wiwanitkit V. Dengue after COVID‐19 vaccination: possible and might be missed. Clin Appl Thromb Hemost . 2021. 10.1177/10760296211047229 [DOI] [PMC free article] [PubMed]
- 3. Santoro F, Crea P, Pellegrino P, et al. Fever following Covid‐19 vaccination in subjects with Brugada syndrome: incidence and management. J Cardiovasc Electrophysiol . 2022. 10.1111/jce.15596 [DOI] [PMC free article] [PubMed]